Skip to main content
. 2020 Feb 10;11(9):2371–2381. doi: 10.7150/jca.40517

Table 2.

Univariate and multivariate analyses of CXCL5 expression and clinicopathological parameters

Variables Univariate analysis Multivariate analysis
HR 95%CI P value HR 95%CI P value
CXCL5 expression
High vs Low 2.366 1.405-3.983 0.001* 1.565 0.889-2.754 0.120
Age (years)
≤60 vs >60 0.683 0.411-1.135 0.141
Gender
Male vs Female 1.017 0.601-1.720 0.951
T stage
T3 vs T1-2 2.524 1.342-4.747 0.004* 2.536 1.286-5.001 0.007*
N stage
N2 vs N0-1 2.69 1.548-4.674 0.000* 2.144 1.179-3.898 0.012*
Differentiation
Poor vs Well/moderate 2.518 1.472-4.307 0.001* 2.342 1.312-4.182 0.004*
Perineural invasion
Positive va Negative 1.373 0.740-2.548 0.315
CA19-9 (U/ml)
≥34 vs <34 3.282 1.611-6.684 0.001* 2.495 1.092-5.703 0.030*
CA242 (U/ml)
≥20 vs <20 2.056 1.204-3.510 0.008* 1.304 0.706-2.409 0.397